DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Antibody Production Market - Forecast, 2014-2025" report to their offering.
The global antibody production market is expected to reach a value of USD 22.6 billion by 2025.
Increasing demand for therapeutic antibodies including monoclonal and polyclonal antibodies is a major factor that drives growth of the market during forecast period. Antibodies are the dominant biopharmaceuticals that specifically target the abnormal cells. Thus, many pharmaceuticals and biotechnology companies have begun to focus on the development of advanced antibodies for the treatment of chronic diseases such as cancer, rheumatic heart disease, and arthritis.
Patent expiry of several blockbuster monoclonal antibodies in the near future, is another major factor supporting the growth of the antibody production market. Several antibodies such as Avastin, Herceptin, and Mabthera are going to lose their patents in a few years. For instance, the patent of Herceptin (trastuzumab) expired in Europe in July 2014 and will expire in the U.S. in June 2019. Many companies such as Amgen Inc., Synthon, Biocon, and Pfizer Inc. are developing biosimilar for trastuzumab, which is expected to propel the demand for antibody production products.
Downstream processing was the largest revenue-grossing segment of the antibody production market in 2016. It is also expected to exhibit the highest CAGR during the forecast period, owing to large application of chromatography devices and resins in downstream processing.
- GE Healthcare
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- Merck KGaA
- Pall Corp.
- Eppendorf AG
- Cellab GmbH
INTEGRA Biosciences AG
Key Topics Covered:
1 Research Methodology
2 Executive Summary
3 Antibody Production Market Variables, Trends & Scope
4 Antibody Production Market: Process Estimates & Trend Analysis
5 Antibody Production Market: Type Estimates & Trend Analysis
6 Antibody Production Market: End-Use Estimates & Trend Analysis
7 Antibody Production Market: Regional Estimates & Trend Analysis, by Process, Type, End-Use
8 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/rbxjg9/antibody